Annual Total Expenses
$1.00 B
-$8.79 M-0.87%
31 December 2023
Summary:
Ultragenyx Pharmaceutical annual total expenses is currently $1.00 billion, with the most recent change of -$8.79 million (-0.87%) on 31 December 2023. During the last 3 years, it has risen by +$270.31 million (+36.87%). RARE annual total expenses is now -0.87% below its all-time high of $1.01 billion, reached on 31 December 2022.RARE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$271.48 M
+$8.09 M+3.07%
30 September 2024
Summary:
Ultragenyx Pharmaceutical quarterly total expenses is currently $271.48 million, with the most recent change of +$8.09 million (+3.07%) on 30 September 2024. Over the past year, it has increased by +$22.04 million (+8.84%). RARE quarterly total expenses is now -14.03% below its all-time high of $315.77 million, reached on 30 September 2022.RARE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RARE Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.8% |
| 3 y3 years | +36.9% | +46.0% |
| 5 y5 years | +90.1% | +108.8% |
RARE Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.9% | +36.9% | -14.0% | +46.0% |
| 5 y | 5 years | -0.9% | +90.1% | -14.0% | +117.6% |
| alltime | all time | -0.9% | >+9999.0% | -14.0% | +5703.4% |
Ultragenyx Pharmaceutical Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $271.48 M(+3.1%) |
| June 2024 | - | $263.39 M(-3.9%) |
| Mar 2024 | - | $274.18 M(+9.9%) |
| Dec 2023 | $1.00 B(-0.9%) | $249.44 M(+2.6%) |
| Sept 2023 | - | $243.15 M(-5.1%) |
| June 2023 | - | $256.27 M(+0.7%) |
| Mar 2023 | - | $254.60 M(+2.3%) |
| Dec 2022 | $1.01 B(+38.1%) | $248.98 M(-21.2%) |
| Sept 2022 | - | $315.77 M(+36.7%) |
| June 2022 | - | $230.94 M(+6.6%) |
| Mar 2022 | - | $216.57 M(+16.5%) |
| Dec 2021 | $733.14 M(+22.0%) | $185.95 M(+8.4%) |
| Sept 2021 | - | $171.47 M(+1.0%) |
| June 2021 | - | $169.75 M(-17.6%) |
| Mar 2021 | - | $205.96 M(+9.8%) |
| Dec 2020 | $601.15 M(+13.9%) | $187.62 M(+42.4%) |
| Sept 2020 | - | $131.78 M(+5.6%) |
| June 2020 | - | $124.76 M(-20.5%) |
| Mar 2020 | - | $156.97 M(+20.7%) |
| Dec 2019 | $527.89 M(+24.8%) | $130.04 M(-9.6%) |
| Sept 2019 | - | $143.83 M(+5.3%) |
| June 2019 | - | $136.62 M(+16.4%) |
| Mar 2019 | - | $117.39 M(+10.1%) |
| Dec 2018 | $422.87 M | $106.60 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $101.41 M(-5.8%) |
| June 2018 | - | $107.69 M(+0.5%) |
| Mar 2018 | - | $107.16 M(+8.0%) |
| Dec 2017 | $331.55 M(+33.6%) | $99.25 M(+18.3%) |
| Sept 2017 | - | $83.91 M(+7.0%) |
| June 2017 | - | $78.44 M(+12.1%) |
| Mar 2017 | - | $69.95 M(-0.9%) |
| Dec 2016 | $248.14 M(+68.0%) | $70.55 M(+7.1%) |
| Sept 2016 | - | $65.89 M(+13.5%) |
| June 2016 | - | $58.07 M(+8.3%) |
| Mar 2016 | - | $53.62 M(-4.5%) |
| Dec 2015 | $147.74 M(+160.2%) | $56.16 M(+40.6%) |
| Sept 2015 | - | $39.94 M(+32.5%) |
| June 2015 | - | $30.14 M(+40.2%) |
| Mar 2015 | - | $21.50 M(+26.9%) |
| Dec 2014 | $56.78 M(+75.9%) | $16.94 M(+7.0%) |
| Sept 2014 | - | $15.84 M(+15.9%) |
| June 2014 | - | $13.66 M(+32.1%) |
| Mar 2014 | - | $10.34 M(+8.5%) |
| Dec 2013 | $32.28 M(+101.9%) | $9.53 M(+22.7%) |
| Sept 2013 | - | $7.76 M(-5.9%) |
| June 2013 | - | $8.25 M(+22.2%) |
| Mar 2013 | - | $6.75 M(+44.2%) |
| Dec 2012 | $15.98 M(+143.6%) | $4.68 M |
| Dec 2011 | $6.56 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual total expenses?
- What is the all time high annual total expenses for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly total expenses?
- What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly total expenses year-on-year change?
What is Ultragenyx Pharmaceutical annual total expenses?
The current annual total expenses of RARE is $1.00 B
What is the all time high annual total expenses for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual total expenses is $1.01 B
What is Ultragenyx Pharmaceutical quarterly total expenses?
The current quarterly total expenses of RARE is $271.48 M
What is the all time high quarterly total expenses for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly total expenses is $315.77 M
What is Ultragenyx Pharmaceutical quarterly total expenses year-on-year change?
Over the past year, RARE quarterly total expenses has changed by +$22.04 M (+8.84%)